New compounds specifically inhibit NLRP3 in mouse models and human cells Series includes orally active…
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Kriya Therapeutics, Inc., a fully integrated gene…
SAN FRANCISCO–(BUSINESS WIRE)–Global Retail Intelligence leader Intelligence Node announces several strategic hires to accelerate its…
JetBlue’s proposal offers Spirit’s shareholders and other stakeholders more value, more certainty and more opportunity…
TOKYO & NEW YORK–(BUSINESS WIRE)–On September 21, 2021, MUFG and MUFG Bank, a core banking…
New features and capabilities bolster Kubernetes security across the board, help apply shift-left security to…
PARIS–(BUSINESS WIRE)–Transatel – subsidiary of NTT since 2019 – announces the worldwide deployment of a…
TOKYO & NEW YORK–(BUSINESS WIRE)– Mitsubishi UFJ Financial Group, Inc. (MUFG) MUFG Bank, Ltd. MUFG…
Nuvias partners gain access to the entire Armis portfolio, addressing the considerable asset visibility market…
De nouvelles données de l’essai en ouvert PLEO-CMT-FU montrent un bénéfice durable de PXT3003 chez…
New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial,…
New Data from the Open-Label PLEO-CMT-FU Trial Shows Sustained Benefit with PXT3003 in Patients with…
SOM Biotech signs licensing agreement with the University of Minnesota Barcelona, Spain, 16 May 2022….
This credit facility is intended to support the progress and expansion of Inventiva’s pipeline The…
Analysis of primary study endpoint was completed with 7 patients showing a measurable residual disease…
Press Release Nicox Announces a New Governance Structure New governance structure with a separation of…
Saint-Herblain (France), May 16, 2022 – Valneva SE, a specialty vaccine company, today announced that…
GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company…
Saint Herblain (France), May 16, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
— The FDA has accepted an IND application supporting clinical development of ANG-3070 in IPF…